Awareness and use of folic acid among women of childbearing age in Benue State, Nigeria

Autor: Ubong Akpan Okon, Baffa Sule Ibrahim, Rabi Usman, Elizabeth Adedire, Muhammad Shakir Balogun, Adebola Olayinka

Publikováno v: The Pan African Medical Journal, Vol 37, Iss 60 (2020)

INTRODUCTION: Every year in Nigeria 12,695 babies are born with neural tube defects. Folic acid reduces the risk of neural tube defect by about 50% among peri-conceptional users. We conducted this study to determine the awareness and use of folic aci

Externí odkaz: https://doaj.org/article/bc87a868f78a457abedf0a8361dafd4c

Evaluation of the Nigeria national HIV rapid testing algorithm.

Autor: Iriemenam NC; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Mpamugo A; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Ikpeazu A; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria., Okunoye OO; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Onokevbagbe E; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Bassey OO; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Tapdiyel J; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Alagi MA; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Meribe C; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Ahmed ML; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Ikwulono G; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria., Aguolu R; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria., Ashefor G; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria., Nzelu C; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria., Ehoche A; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Ezra B; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Obioha C; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Baffa Sule I; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Adedokun O; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Mba N; National Reference Laboratory, Nigeria Centers for Disease Control, Gaduwa, Federal Capital Territory, Nigeria., Ihekweazu C; National Reference Laboratory, Nigeria Centers for Disease Control, Gaduwa, Federal Capital Territory, Nigeria., Charurat M; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Lindsay B; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Stafford KA; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Ibrahim D; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Swaminathan M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria., Yufenyuy EL; International Laboratory Branch, Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Parekh BS; International Laboratory Branch, Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Adebajo S; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria., Abimiku A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Okoye MI; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2022 Nov 02; Vol. 2 (11), pp. e0001077. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).